22 May 2013
Keywords: novartis, file, prexige, year-end, said, still, expects
Article | 17 June 2002
Novartis has said that it still expects to file a New Drug Applicationin the USA for its COX-2 inhibitor Prexige ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 June 2002
21 May 2013
© 2013 thepharmaletter.com